Some patents tied to the injection device used for Zepbound and Mounjaro may expire earlier, but the most important protections involve tirzepatide itself
Carbamidomethylation was set as a fixed modification, whereas methionine oxidation, asparagine and glutamine deamination, and glycosylation options were set as variable modifications, according to published data (Lebede et al., 2021)
Studying its influence on energy expenditure and fat oxidation processes
Competitive Landscape: Some of the major market players in the GLP-1 receptor agonist industry include Amgen Inc., Eli Lilly and Company, Hanmi Pharm Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Novo Nordisk A/S, Paige Biomedicine (Suzhou) Co., Ltd., Sanofi S.A., among many others
Then, everywhere you turn, you hear about GLP-1 medications a class of drugs known as GLP-1 receptor agonists that includes semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) which mimic your body's natural GLP-1 hormone to help regulate blood sugar and appetite